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Highlights 
 A decrease in impeller speed to below NJS caused sampling difficulties and clumping. 
 An increase to ~2 NJS decreased the growth rate though an intermediate value of ~1.3 NJS did 
not. 
 Cell quality remained unchanged post-harvest. 
 Direct aeration both with and without Pluronic F68 at NJS was detrimental to BM-hMSC 
growth. 
 Cell quality was detrimentally impacted compared to headspace aeration. 
 
Abstract 
The impact of agitation rate and sparged aeration on BM-hMSC expansion in conventional stirred tank bioreactors 
was assessed. It was found that a decrease in impeller speed to below NJS caused sampling difficulties, clumping 
and an increase to ~2 NJS decreased the growth rate though an intermediate value of ~1.3 NJS did not. Additionally, 
over this range of agitation intensities, cell quality remained unchanged post-harvest suggesting that poor growth 
performance at the highest speed was due to a failure of the cells to attach efficiently to microcarriers rather than 
damage to the cells due to fluid dynamic stress. Further it was shown that direct aeration of the culture medium 
both with and without Pluronic F68 via a sparger at NJS was detrimental to BM-hMSC growth. Again, this 
reduction in growth seems to be associated with poor attachment rather than cell damage, which due to the 
mechanism of PluronicTM F68 reducing the cell hydrophobicity and thus the affinity of the BM-hMSCs to attach 
to the microcarrier, leads to a poorer performance in the presence of the surfactant. Certain post-harvest quality 
characteristics are also detrimentally impacted compared to headspace aeration. This problem is discussed in terms 
of the need to facilitate future large-scale process development where headspace aeration at NJS may not be 
sufficient to meet culture needs at higher cell densities. 
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1. Introduction 
Bone marrow-derived human mesenchymal stem cells (BM-hMSCs) have generated much interest in the field of 
regenerative medicine and cell-base therapies, with the potential to treat and in some cases, cure human disease. 
This interest has been largely driven by their ability to proliferate under appropriate culture conditions and their 
capacity to secrete a range of trophic factors which regulate host immune response and initiate tissue repair [1]. 
Consequently, there have been approvals for BM-hMSC-based products and multiple trials involving the use of 
the cells are advancing through clinical development targeting indications such as cardiac repair, neurological 
disease and immune disorders [2]. Microcarriers have been used to culture adherent cells such as BM-hMSCs in 
suspension [3] allowing for process scale-up, where online monitoring and control systems can be used to deliver 
a consistent and cost-effective BM-hMSC therapy. Further to this, stirred-suspension bioreactors are currently 
employed in biopharmaceutical production and therefore their design and operation are well-understood [4], with 
the potential to meet the expected manufacturing demands of large-scale BM-hMSC therapies [5].  
 
If the bioreactor is to work effectively, it is essential that the microcarriers are at least fully suspended in such a 
way that though they may regularly touch and move on the bottom, they do not remain stationary for any 
significant period of time, typically 5 s; that condition requires a certain minimum agitator speed to achieve it 
(usually given the symbol, NJS (rev/s)) [6]. Under these conditions, the cells on the microcarrier are always 
surrounded by culture medium and are therefore able to take up nutrients (including O2) from it and secrete 
growth-inhibiting metabolites into it. There is much emphasis in the literature on the sensitivity of cells grown on 
microcarriers to high fluid dynamic stresses generated by agitation such that the culture performance is poor 
whether dealing with animal cells for vaccine production or stem cells. There are a number of mechanisms that 
can give rise to mechanical stress on microcarriers and the cells on them; fluid motion relative to the microcarrier, 
impacts between microcarriers and the impeller or between microcarriers, and from bursting bubbles associated 
with the cells’ oxygen demand. When growing cells, there are two ways in which culture may be compromised; 
one is growth and proliferation and the other, of critical importance for regenerative medicine and cell-based 
therapy applications, is cell or product quality. In the case of BM-hMSC, the cell forms the basis of the product. 
These issues in turn may arise for two reasons: the stress will detach the cells from the microcarriers and 
subsequently performance will be compromised or the stress will damage the cell while still on the microcarrier. 
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Meeting the oxygen demand of cells is often considered the process requirement needing the highest agitation 
intensity. At the cell density currently achievable and operating scale used at present when growing stem cells on 
microcarriers, in general, the most demanding agitation has been that required for microcarrier suspension and at 
this condition, the oxygen demand can be met by surface aeration. The same situation existed in the early days of 
free suspension mammalian cell culture, even though cell oxygen demand is an order of magnitude higher than 
BM-hMSCs [3]. But as cell densities increased to greater than 5 x 106 cells ml-1 and bioreactor scale increased, 
up to 25 m3, aeration directly into the culture medium via the incorporation of a sparger had to be used [6]. This 
situation is likely to arise with stem cells in the future and this change may also create new challenges; for example, 
the addition of antifoam [7] into the medium, which has been previously shown to significantly reduce the mass 
transfer rate of the system [8]. It is also widely accepted that cell damage due to direct aeration in free suspension 
culture is primarily a result of cells attaching to bubbles and experiencing the huge energy release as they burst at 
the medium-air interface. Polymers such as PluronicTM F68 are widely used to decrease this cell damage and 
improve bioreactor performance [9, 10]. This improvement in performance by the addition of PluronicTM F68 is 
a result of its ability to reduce the hydrophobicity of the cell surface, preventing cell-bubble attachment and 
subsequent damage [11].  
 
The aim of this study therefore, is to assess the impact of impeller agitation rate on BM-hMSC expansion in stirred 
bioreactors and the influence of direct aeration into the culture medium on the growth and characterization of BM-
hMSC, to facilitate future large-scale development where headspace aeration at NJS may not be sufficient.  
 
 
2. Materials & Methods 
2.1 Monolayer Culture 
BM-hMSCs were isolated from bone-marrow aspirate purchased from Lonza (Walkersville, USA) obtained from 
a healthy donor with informed consent (lot: 071313B).  The local Ethical Committee approved the use of the 
sample for research.  Cells from passage 1 were cryopreserved at a density of 1-2 x 106 cells.ml-1 in a freeze 
medium containing 90% (v/v) FBS (Hyclone, Belgium) and 10% (v/v) dimethylsulphoxide (Sigma-Aldrich, UK). 
Cells were grown in T-flasks seeded at 5,000 cells.cm-2 at 37°C in humidified air containing 5% CO2. For serum-
free culture, the growth surface of T-flasks was coated with 0.4 µg.cm-2 PRIME-XV human fibronectin (FN) 
(Irvine Scientific, USA) and cultured in PRIME-XV MSC Expansion SFM (Irvine Scientific, USA) as per the 
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manufacturer’s instructions. On passage, the hMSCs were washed with phosphate buffered saline without Ca+ or 
Mg+ (PBS) and incubated for 4 min with TrypLE Express (Invitrogen, UK). Dissociation reagents were inactivated 
by the addition of appropriate growth medium and the cell suspension was centrifuged at 220g for 5 min. The 
supernatant was discarded and the remaining pellet was re-suspended in an appropriate volume of culture medium. 
BM-hMSCs underwent one adaptation passage in serum-free medium.    
 
 
2.2 DASGIP DASbox bioreactor microcarrier culture 
The glass surfaces of 250 ml DASGIP DASbox bioreactors (diam. T = 60 mm) (Eppendorf, Germany) were 
siliconized with Sigmacoat (Sigma-Aldrich, UK) according to manufacturer’s instructions to prevent cell 
attachment to the surface of the bioreactor and impeller.  The bioreactors were equipped with a 3-blade 30°-pitch, 
down pumping impeller (diameter, D = 30.25 mm), a temperature probe, a Hamilton dissolved oxygen (dO2) 
probe, a Hamilton pH probe, an off-gas analyser and two sterile sample ports. Solid, non-porous Plastic P-102L 
microcarriers of 160-200 microns (Solohill, USA) were prepared to give 5000 cm2/l per bioreactor following 
manufacturer’s instructions. Microcarriers were coated with 0.1 µg.cm-2 PRIME-XV FN prior to hMSC 
inoculation at 6,000 cells. cm-2 and cultured in 100 ml of PRIME-XV MSC Expansion SFM with bioreactor 
control set-points of 37 °C and pH 7.4.  A 50 % medium exchange was performed every two days as per 
manufacturer’s instructions. Following inoculation, the culture was static for one hour (based on related work on 
optimizing attachment [12]) after which the culture was agitated at NJS (found to be 115 rpm) or at whatever 
agitator speed was selected for that experiment both slightly below NJS and well above it, with daily medium and 
cell-microcarrier samples of 1 ml taken for analysis. The DASbox system was set up, calibrated and controlled 
using the DASGIP DASbox control unit (Eppendorf, Germany) and was operated with headspace aeration to 
achieve sufficient gas supply to give the desired oxygen concentration. 
 
As pointed out above, the aim of this study was to assess the impact of impeller agitation intensity and bubbling 
aeration on BM-hMSC expansion in stirred bioreactors as part of an ongoing program to facilitate future large-
scale development.  The work on the impact of agitation was undertaken first and at that time, our earlier work 
conducted in an oxygen-controlled incubator for both monolayer [13] and spinner flask culture [14] indicated that 
with the same donor cells as cultured here, the performance with respect to growth kinetics was better at 100% 
dO2.than at lower values when cultured over 3 passages. Thus, during the studies of agitation intensity, the dO2 
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was controlled in the DASGIP DASbox bioreactor using the DASGIP DASbox control unit (Eppendorf, Germany) 
and was operated with headspace aeration to give 100% dO2. However, subsequently during the present study in 
the DASGIP DASbox bioreactor [15], it was found that 25% dO2 gave a better performance. So, whilst overall 
some literature studies have shown 100% dO2 gives enhanced growth kinetics and others, lower dO2 values [14], 
it was decided here to study the impact of air sparging at 25% dO2. Thus, when investigating the impact of air 
sparging, the agitator speed was set at NJS and the dO2 was controlled to 25% when sparging at 0.1 VVM and also 
with headspace aeration.  
 
Though both the topics relate to the cells’ sensitivity to fluid dynamic stresses, they can also be viewed as 
somewhat separate issues as the potential mechanisms of damage are different.   
 
2.3 DASGIP DASbox bioreactor harvest 
BM-hMSCs were harvested using a method previously developed by us [16, 17]. Briefly, the DASbox control 
was switched off and the microcarriers allowed to settle. The spent culture medium was removed and the 
microcarriers were washed twice in 50 ml of Ca2+ and Mg2+ free PBS. The PBS was removed before adding 80 
ml of TrypLE Express dissociation reagent for 10 minutes at an impeller speed of 375 rpm (ending with 5 seconds 
at 400 rpm). The dissociation reagent was then quenched with 70 ml of culture medium and a 2 ml sample placed 
in a single well of a 6 well plate for analysis under a light microscope to assess cell detachment. The remainder 
of the solution was filtered through a 60 μm Steriflip Filter Unit (Merck Millipore, Germany) to separate the 
microcarriers from the BM-hMSCs. The cell suspension was centrifuged, the supernatant aspirated and the cell 
pellet re-suspended in culture medium. A cell count was then performed using a NucleoCounter NC-3000 to assess 
the overall hMSC growth and the culture harvest efficiency.  
 
 
2.4 Analytical Techniques 
Analysis of glucose and lactate concentrations in the spent medium was performed using a Cedex Bio-HT (Roche, 
Germany). Cell counting, mean cell diameter and viability (via acridine orange uptake and DAPI exclusion) was 
performed using a NucleoCounter NC-3000 automated mammalian cell counter (Chemometec, Denmark). The 
following parameters were obtained: 
1. Specific Growth Rate 
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𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝑔𝑟𝑜𝑤𝑡ℎ 𝑟𝑎𝑡𝑒, µ =  
ln(
𝐶𝑥(𝑡)
𝐶𝑥(0)
⁄ )
∆𝑡
  
where µ is the net specific growth rate (h-1), Cx(t) and Cx(0) are the cell numbers at the end and start of the 
exponential growth phase, respectively and t is time (h).  
2. Population Doublings 
𝑃𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝐷𝑜𝑢𝑏𝑙𝑖𝑛𝑔𝑠, 𝑃𝑑 =
1
log  (2)
∙ log (
𝐶𝑥(𝑡)
𝐶𝑥(0)
)  
where Pd is the number of population doublings, Cx(t) and Cx(0) are the cell numbers at the end and start of the 
exponential growth phase, respectively. 
3. Specific Metabolite Consumption/Production Rate 
𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝑚𝑒𝑡𝑎𝑏𝑜𝑙𝑖𝑡𝑒 𝑓𝑙𝑢𝑥, 𝑞𝑚𝑒𝑡 = (
𝜇
𝐶𝑥(0)
) ∙ (
𝐶𝑚𝑒𝑡(𝑡)−𝐶𝑚𝑒𝑡(0)
𝑒𝜇𝑡−1
)  
where qmet is the net specific metabolite consumption or production rate, µ is the specific growth rate (h-1), Cx(0) 
is the cell number at the end of the exponential growth phase, Cmet(t) and Cmet(0) are the metabolite concentrations 
at the end and start of the exponential growth phase, respectively and t is time (h).  
 
 
2.5 Colony-forming unit fibroblast (CFU-f) Efficiency 
To assess the CFU-f efficiency, BM-hMSCs were seeded in a T-flask at 10 cells.cm-2 and cultured with a medium 
exchange every 3-5 days. Following 14 days culture, cells were washed with PBS and fixed in 4% formaldehyde 
(v/v) (Sigma, UK) for 30 minutes. Colonies were stained with 1% crystal violet (Sigma, UK) in 100% methanol 
(w/v) for 30 minutes. Stained colonies that were made up of more than 25 cells were recorded as CFUs. 
 
2.6 hMSC Characterisation 
Immunophenotype analysis was performed by multi-parameter flow cytometry before and after the hMSC 
expansion process using a previously developed protocol [18]]. Short Tandem Repeat analysis was completed by 
LGC Standards (UK) under their cell line authentication program. Morphology images were obtained using a light 
microscope (Nikon Eclipse TS-100, UK). 
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The hMSC differentiation was induced using PRIME-XV Differentiation SFM (Irvine Scientific, USA) as per 
manufacturer’s instructions. After 21 days, the differentiation medium was removed, cells rinsed with PBS then 
fixed with 4% (v/v) PFA at room temperature. Adipocytes were stained with 1% (w/v) Oil Red O (Sigma-Aldrich, 
UK) in isopropanol at room temperature and rinsed with distilled water. Osteoblasts were incubated with 2.5% 
(v/v) silver nitrate (Sigma-Aldrich, UK) under ultraviolet light (30 minutes exposure), rinsed with distilled water 
and stained with fast violet solution (Sigma-Aldrich, UK) containing 4% (v/v) napthol AS-MX phosphate alkaline 
(Sigma-Aldrich, UK) for 45 minutes at room temperature in the dark. Chondrocytes were stained with 1% (w/v) 
Alcian blue (Sigma-Aldrich, UK) in 0.1 M hydrochloric acid (Sigma-Aldrich, UK). After 30 minutes incubation, 
cells were rinsed three times with 0.1 M HCl. After staining, differentiated cells were visualized under a light 
microscope (Nikon Eclipse TS-100, UK). 
 
2.7 Statistical Analysis  
Results were deemed to be signiﬁcant if p < 0.05 using a two-tailed Students t-test. 
 
3. Results & Discussion 
3.1 Effect of agitation rate on BM-hMSC culture on microcarriers  
3.1.1 Expansion 
In order to support the successful expansion of BM-hMSCs on microcarriers in suspension bioreactors, it will be 
critically important to employ an agitation strategy that suspends the microcarriers without causing damage to the 
cells throughout scale-up and when higher cell densities are achieved. In order to quantify this requirement, the 
impact of different impeller speeds on the growth of BM-hMSCs on microcarriers has been assessed, whilst 
employing headspace aeration. In conjunction with this assessment, the critical turbulence parameters of the 
bioreactor system have been calculated to provide a strong theoretical basis for this comparison, which can be 
seen in Table 1.  
 
Figure 1A shows the effect of the various impeller speeds on BM-hMSC growth from daily samples over six days, 
with the highest impeller speed of 225 rpm leading to the lowest BM-hMSC growth. This is confirmed by the 
post-harvest cell counts in Figure 1B, which shows that there is significantly lower (p < 0.05) BM-hMSC growth 
at the highest impeller speed. The minimum impeller speed to suspend the microcarriers (NJS) was visually 
determined to be 115 rpm. Maintaining the microcarriers and cells in suspension is critical to ensure that effective 
AC
CE
PT
ED
 
AN
US
CR
IPT
 9 
 
mass transfer can take place [19] and to prevent attachment to the base of the bioreactor as well as severe cell-
microcarrier clumping [14]. In addition, sampling during the run at 80 rpm was somewhat problematic as the 
microcarriers and cells were not entirely suspended and this explains why the daily cell concentration at 80 rpm 
(Figure 1A) was low compared with the post-harvest total cell number (Figure 1B).  Therefore, though the post-
harvest total cell number was the highest at this speed, the impeller speed in this microcarrier-based bioreactor 
system should still be at least 115 rpm.  
Table 1 shows the characterization of the bioreactor system at different impeller speeds with a calculation of the 
Kolmogorov microscale of turbulence for each impeller speed [17]. Considering that the size of the microcarriers 
used in this study are in the range of 125-212 µm (mean size ~ 170 µm), Table 1 shows that the Kolmogorov 
microscale at each of the investigated impeller speeds is much less than the size of the microcarriers but much 
bigger than a BM-hMSC (~ 15 to 20 µm).  Kolmogorov theory suggests that the eddies most likely to cause 
damage are those of the size of the suspended entity i.e. turbulent eddies which are the same size as the cell in 
free-suspension culture [20]. Croughan et al  [20] investigated the impact of this microscale of turbulence on 
animal cells grown on microcarriers, with cell damage becoming significant when the microscale was less than 
or equal to about two-thirds the size of the microcarriers. A similar result was found for the conditions used here 
in spinner flasks [17]. However, as found in studies in other agitated bioreactors of 15 ml and 5 l [17], based on 
the mean microcarrier size, that BM-hMSC growth kinetics were not affected at NJS (115 rpm) even though the  
turbulent eddy size was < ~ 40% of the size of the microcarrier. Indeed, at 150 rpm (specific power input 0.06 
W/kg) where the microscale was 1/3 of the size of the microcarrier, similar to that at NJS in the 15 ml ambr [17], 
the growth rate was similar (p > 0.05) to that measured at NJS, which is beneficial as the increased mean specific 
energy dissipation rate would enable higher oxygen demands to be met. At 225 rpm (mean specific energy 
dissipation rate 0.2 W/kg), the Kolmogorov scale is <  25% of that of the microcarriers and a severe reduction in 
performance was detected.  
 
3.1.2 Metabolite flux  
The relative flux of metabolites is an important parameter to measure and understand during the expansion process 
as it has the potential to form part of a process control system, based upon BM-hMSC characteristics. Figure 2A 
and B shows the lactate dehydrogenase (LDH) and total protein concentration at the various impeller speeds 
throughout the culture process, which do not increase as the impeller speed is changed. If cell damage was 
occurring during the culture process, the levels of LDH and total protein would increase [21]. The differences in 
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BM-hMSC growth kinetics due to changes in impeller speed are therefore not attributed to cellular damage by 
membrane disruption in this instance. It has been demonstrated previously however, that increasing the shear 
stress in flow chambers during BM-hMSC culture leads to the inhibition of proliferation, in association with 
maintaining cells in the G0/G1 phase of the cell cycle [22]. Additionally, the reduction in growth kinetics at higher 
impeller speeds could be caused by an inhibition of BM-hMSC attachment and re-attachment to the microcarriers 
during the growth phase. Whatever the mechanism for the reduced growth rate of BM-hMSCs on microcarriers 
at increased impeller speeds, it is not caused by direct cell damage as is commonly assumed.  
The net flux of each metabolite can be seen in Figure 3A and B, which shows an increase in ammonia production 
and yield of lactate from glucose at higher impeller speeds. The effect of impeller speed on the live metabolite 
concentrations during BM-hMSC expansion in controlled microcarrier culture can be seen in Supplementary 
Figure 1. The increased ammonia production at an impeller speed suggests altered amino acid utilisation, which 
may be related to the increased need for precursors (e.g., glutamine and asparagine) supporting purine, and 
pyrimidine biosynthesis [23]. The yield of lactate from glucose for impeller speeds of 80, 115 and 150 rpm was 
around 2 mol.mol-1 which indicates that the cells mainly metabolise glucose via the inefﬁcient glycolytic pathway 
instead of oxidative phosphorylation [24]. The impeller speed of 225 rpm had a yield of lactate from glucose of 
2.70 ± 0.73 mol.mol-1 which is above the theoretical maximum yield of 2 mol.mol-1 [25]. The high figure at 225 
rpm suggests that an additional carbon source, most likely glutamine, is being metabolised to produce lactate and 
ammonia, resulting in higher lactate yields and an increase in the per cell ammonia flux [3] seen in Figure 3A.  
These findings are in line with previously published articles for both microcarrier and monolayer culture [26, 27].     
 
3.1.3 Quality characteristics 
In addition to the growth kinetics and metabolite flux, it is important to assess the post-harvest BM-hMSC 
characteristics to ensure that the process and harvest conditions have not had a detrimental impact on the quality 
of the cell [16]. The BM-hMSCs were harvested from the microcarrier surface and separated prior to 
characterization according to a previously published protocol for the DASGIP DASbox bioreactor platform [17], 
maintaining a post-harvest viability of >95% in all conditions. The specific outgrowth rate can be seen in Figure 
4A which shows that the BM-hMSC post-harvest outgrowth rate was similar across all the impeller speeds 
investigated in the bioreactor. This similarity suggests that the impeller speed of 225 rpm has not triggered a 
senescent state in the BM-hMSCs or caused detriment to their outgrowth potential. This result is further evidence 
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to support the hypothesis that the reduction of BM-hMSC growth kinetics on microcarriers at high impeller rates 
is due to inefficient cell-microcarrier attachment, rather than cell damage due to increasing fluid dynamic stresses. 
This finding also gives further support to the use of high agitation intensity as an aid to cell detachment during 
harvest [16, 17].  
 
It can also be seen from Figure 4A that the post-harvest outgrowth kinetics of BM-hMSCs from the controlled 
DASbox bioreactor system at all impeller speeds were higher than either before expansion and post-harvest from 
the relatively-uncontrolled spinner flask process. This higher rate is an indication of the positive impact that 
control of the environment in the bioreactor is having on the BM-hMSC characteristics, which will be important 
for future bioprocess scale-up and development.       
 
Associated with the increase in post-harvest outgrowth, the BM-hMSCs cultured in the DASbox bioreactor 
platform had a reduced mean cell diameter (Figure 4B) for all impeller speeds compared to pre-expansion and 
post-harvest from relatively-uncontrolled spinner flasks. As well as being associated with a decrease in BM-hMSC 
growth rate [28], an increase in cell size has been linked to aging of BM-hMSCs and loss in differentiation 
potential [29, 30] and therefore a reduction in BM-hMSC size through controlled microcarrier expansion will be 
beneficial to the manufacturing process. Colony forming potential has been highlighted as an important assay for 
the quality of BM-hMSC preparations [31] and is known to deteriorate during culture [32, 33]. Figure 4C shows 
the maintenance of colony forming potential from pre-expansion to post-harvest at all impeller speeds, which 
further demonstrates that the BM-hMSCs have not been damaged during the expansion and harvest process. 
Furthermore, BM-hMSCs have retained their immunophenotype and differentiation potential according to the 
ISCT minimum criteria (supplementary Figure 2).   
 
3.2 Effect of sparged aeration on BM-hMSC culture on microcarriers 
3.2.1 Expansion 
Like agitation intensity, aeration strategies will play a key role in the successful development of microcarrier based 
bioreactor processes for BM-hMSC manufacture, particularly as the scale of operation and product cell density 
increases. Due to the fact that the speciﬁc oxygen demand and the cell densities achieved so far in BM-hMSC 
microcarrier culture are low, the oxygen demand of the cells in current benchtop bioreactors can be met by passing 
gas mixtures through the headspace. However, at the commercial scale, as the surface area to volume ratio is 
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inversely proportional to scale, sparging will probably be required [4]. This issue is particularly important because 
in free suspension culture, bursting bubbles can be much more damaging than agitation and the addition of 
Pluronic F68 is required to prevent it [4].  
 
To address this issue, BM-hMSCs have been cultured with sparged sub-surface aeration at 0.1 VVM, with and 
without PluronicTM F68 in the medium, and compared to headspace aeration, (all with dO2 controlled at 25%).  
Figure 5A shows the growth rate over six days of bioreactor expansion, demonstrating that headspace aeration 
(1.70 ± 0.45 x 105 cell.ml-1 or 3.4 ± 0.9 x 104 cell.cm-2) supports significantly higher (p < 0.05) growth kinetics 
compared to sparged culture with (0.52 ± 0.15 x 105 cell.ml-1 or 1.04 ± 0.3 x 104 cell.cm-2) and without (0.84 ± 
0.18 x 105 cell.ml-1 or 1.68 ± 0.36 x 104 cell.cm-2) PluronicTM F68. This study is the first indication that aeration 
directly into the culture medium via a sparger has a detrimental impact on the expansion of BM-hMSCs on 
microcarriers. The cells ml-1 after 6 days when sparging in the presence of PluronicTM F68 is slightly higher than 
without it; and both are markedly lower than with headspace aeration. Interestingly, the addition of this surfactant  
has been shown to be effective in an alternative cell-microcarrier culture [34].  
This results suggests that the detrimental impact of direct aeration on the microcarrier culture of BM-hMSCs is 
not simply due to cell-bubble attachment, with cell damage caused by subsequent bubble bursting at the gas-liquid 
interface as is the case with free suspension cell culture [11]. The key difference with the microcarrier culture of 
BM-hMSCs compared to free suspension cell culture is that the cells must adhere to the microcarrier surface prior 
to growth. The addition of PluronicTM F68 into the culture medium in this system is in fact having a detrimental 
impact on the growth of BM-hMSCs, which perhaps is not surprising given that the mechanism of PluronicTM F68 
is to reduce the cell hydrophobicity, thus reducing the affinity of the BM-hMSCs to attach to the microcarrier or 
bubble surface. Further evidence of this hypothesis can be seen in Figure 5B, which shows the attachment rate of 
the BM-hMSCs to the microcarriers during the six days of culture. This figure shows that the attachment rate of 
the BM-hMSCs is reduced in sparged culture compared to headspace aeration, suggesting that introducing bubbles 
into the bioreactor system is disrupting the BM-hMSC attachment process. Additionally, the inclusion of 
PluronicTM F68 in the culture medium is further reducing the attachment rate of the BM-hMSCs to the 
microcarriers in suspension, in accordance with the mechanism described above. This reduced attachment rate of 
BM-hMSCs is likely to be contributing to the reduced growth rate seen under sparged conditions for BM-hMSCs 
cultured on microcarriers.  
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3.2.2  Metabolite flux  
In addition to growth rate, the metabolite flux has been monitored throughout culture to assess the impact that 
direct aeration is having on the consumption and production of metabolites throughout microcarrier culture. Figure 
6A, B and C show the per cell flux of glucose, lactate and ammonia respectively and Figure 6D, the yield of lactate 
from glucose throughout the six days of expansion for sparged and headspace aeration culture. These figures show 
that despite the reduced growth rate, the net flux of glucose, lactate and ammonia is similar for all conditions and 
again did not reach previously determined inhibitory levels at any point [35]. The per cell flux of each metabolite 
shows a similar level of net glucose consumption per cell in headspace and sparged aeration during culture. In 
contrast, the production of ammonia to above 3 pmol.cell-1.day-1 and lactate to above 20 pmol.cell-1.day-1 in 
sparged culture was significantly higher (p < 0.05) than from headspace aeration. The increase in the per cell 
production of lactate and ammonia has previously been associated with a reduction in growth kinetics of BM-
hMSCs throughout an expansion process [33]. As with the previous experiments, the LDH and total protein 
concentrations have been measured to assess whether any BM-hMSC stress or damage has been caused by sparged 
aeration. Supplementary Figures 3A and B show these concentrations throughout culture, which have not 
increased over the six-day period in any condition. This finding is further evidence to suggest that introducing 
sparged aeration into the culture is not causing cell damage by bubble bursting, as the level of LDH and total 
protein would be increasing throughout culture if cell damage was occurring, which is the likely reason why the 
addition of PluronicTM F68 into sparged culture is not improving the BM-hMSC growth rate on microcarriers. 
Considering that cell damage is not occurring during sparged aeration, this provides further evidence that the 
reduction in growth rate during direct aeration is caused by the reduction in attachment rate at the start of culture 
or increased detachment during culture.  
3.2.3 Quality characterization  
The post-harvest BM-hMSC number in Figure 7A further supports the previous findings, that a significantly 
higher (p < 0.05) number of BM-hMSCs were produced under headspace aeration, compared to sparged aeration 
in the controlled bioreactor process. Figure 7D shows that the post-harvest BM-hMSC mean diameter is increased 
for sparged culture, with a significant increase (p < 0.05) seen for sparged aeration with the addition of PluronicTM 
F68. This increase in post-harvest cell size is associated with a reduction in BM-hMSC attachment and subsequent 
growth rate with the addition of PluronicTM F68, as was seen previously for an impeller speed of 225 rpm. In 
addition to the increased post-harvest BM-hMSC diameter, the addition of PluronicTM F68 into the sparged culture 
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lead to a reduction in BM-hMSC outgrowth kinetics (Figure 7C) as well as a significant reduction (p < 0.05) in 
the CFU potential of the BM-hMSCs (Figure 7B). This reduction raises concerns about the use of PluronicTM F68 
in the culture of BM-hMSCs on microcarriers and its inclusion in cell-based therapy manufacturing processes 
should be carefully considered to ensure that it is not having a detrimental impact on the growth or quality of the 
cell product.   
 
4.  Conclusions 
A range of impeller agitation speed have been used during the microcarrier expansion of BM-hMSCs from values 
below the minimum required to just suspend the microcarriers, NJS, (the commonly recommended value for 
culture) to values ~ 2 NJS. The lower value was to assess the impact of poor suspension; and higher values, the 
impact when the O2 demand cannot be met at NJS due to increasing cell density or scale.  Though the decrease to 
below NJS gave the highest post-harvest total cell number, there were inconsistencies between pre and post because 
of sampling difficulties. In addition, poor suspension leads to increased clumping. At the other extreme at a speed 
of ~ 2 NJS, the growth rate significantly decreased. However, at ~ 1.3 NJS, the results were very similar to those at 
NJS, indicating the potential for higher mass transfer rates from agitation. In addition, over this range of agitation 
intensity, there was not any detrimental impact on the BM-hMSC post-harvest re-growth characteristics.  
 
Direct aeration of the culture medium both with and without Pluronic F68 in it via a sparger at NJS, again relating 
to potential increasing mass transfer needs, has also been shown to be detrimental to BM-hMSC growth and 
certain post-harvest quality characteristics compared to headspace aeration. Direct aeration of the medium during 
bioreactor culture is not only likely to be required at the large-scale to supply oxygen to the cells but as importantly, 
to remove carbon dioxide. It is currently the preferred method of aeration and CO2 stripping in large scale 
bioreactors for free suspension cell culture. Therefore, it will potentially be important during process scale-up; 
and to ensure that bioreactor parameters such as the specific energy dissipation rate and sparged aeration rates are 
not increased above levels which might affect the growth and quality characteristics of the BM-hMSC product. 
Thus, alternative methods of supplying sufficient levels of oxygen to microcarrier bioreactor systems culturing 
BM-hMSCs may have to be developed as well as establishing the level of pCO2 that they can tolerate as these 
systems are scaled up to manufacture commercially-viable cell numbers.  
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Figure Legends 
Figure 1 – Effect of bioreactor impeller speed on BM-hMSC growth over six days of culture in the DASbox 
controlled bioreactor, showing (A) the increased cell concentration in the bioreactor over six days at all impeller 
speeds, (B) the significant fall (p < 0.05) in total post-harvest cell number at the highest impeller speed. Control 
set-points are 100% dissolved oxygen and pH 7.4 with headspace aeration. Data shows mean ± SD, n = 3. 
 
 
Figure 2 – Effect of impeller speed on A) the production of lactate dehydrogenase (LDH) and B) total protein 
concentration during microcarrier culture of BM-hMSCs in a controlled bioreactor. Showing no significant 
increase in LDH concentration or total protein at various impeller speeds, demonstrating low levels of cell damage 
during culture. Data shows mean ± SD, n = 3.  
AC
CE
PT
ED
 M
AN
US
CR
IPT
 19 
 
 
Figure 3 – Effect of bioreactor impeller speed on BM-hMSC metabolite flux over six days of culture in the 
DASbox controlled bioreactor, showing (A) per cell flux of ammonia and (B) yield of lactate from glucose. 
Control set-points are 100% dissolved oxygen and pH 7.4 with headspace aeration. Data shows mean ± SD, n = 
3. 
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Figure 4 – Post-harvest characteristics of BM-hMSCs from controlled microcarrier culture compared to spinner 
flasks [14]. Showing (A) increased outgrowth kinetics, (B) reduced mean cell diameter and (C) maintained CFU 
efficiency all impeller speeds. Data shows mean ± SD, n = 3.        
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Figure 5 – Effect of sparging (VVM = 0.1) with and without PluronicTM F68 on BM-hMSC growth over six days 
of controlled microcarrier culture compared to headspace aeration. Showing (A) significantly increased growth 
rate with headspace aeration (p < 0.05), and (B) reduced BM-hMSC attachment in sparged culture, particularly 
with the addition of PluronicTM F68. Control set-points are 115rpm impeller speed, 25% DO concentration and 
pH 7.4. Data shows mean ± SD, n = 3.  
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Figure 6 – Effect of sparging (VVM = 0.1) with and without PluronicTM F68 compared to headspace aeration on 
BM-hMSC metabolite flux over six days of controlled microcarrier culture . Showing (A) similar glucose 
consumption rate, (B) increased lactate production, (C) significantly increased ammonia production rate (p < 0.05) 
and (D) similar yield of lactate from glucose in sparged culture. Control set-points are 115rpm impeller speed, 
25% dO2 concentration and pH 7.4. Data shows mean ± SD, n = 3.  
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Figure 7 – Effect of sparging (VVM = 0.1) with and without PluronicTM F68 on BM-hMSC attachment and post-
harvest characteristics after six days of controlled microcarrier culture compared to headspace aeration. Showing 
(A) significantly reduced harvest cell number (p < 0.05), (B) decreased CFU efficiency, (C) similar specific 
outgrowth rate and (D) significantly increased mean cell diameter in sparged culture (p < 0.05). Control set-points 
are 115rpm impeller speed, 25% dO2 concentration and pH 7.4. Data shows mean ± SD, n = 3.  
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Table 1 –Fluid dynamic characterisation of the DASGIP DASbox bioreactor platform at the various impeller 
speeds used in this study (impeller diameter of 0.03 m and a bioreactor diameter of 0.063 m). (Based on the 
procedure set out in Nienow et al. 2016 [17]). 
Impeller 
rate 
(rpm) 
Culture 
volume 
(ml) 
Power 
number1 
Max 
dissipation 
rate/average 
dissipation 
rate1 
Reynolds 
number 
Impeller 
speed 
(s-1) 
Max 
specific 
energy 
dissipation 
rate 
(W/kg) 
Kolmogorov 
scale of 
turbulence 
(µm) 
80 100 1.5 18 1440 1.33 0.016 90 
115 100 1.5 18 2070 1.92 0.046 68 
150 100 1.5 18 2700 2.50 0.103 56 
225 100 1.5 18 4050 3.75 0.346 41 
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